Metabolic syndrome as a cardiovascular disease risk factor : patients evaluated in primary care
To estimate the prevalence of metabolic syndrome (MS) in a population receiving attention in primary care centers (PCC) we selected a random cohort of ostensibly normal subjects from the registers of 5 basic-health area (BHA) PCC. Diagnosis of MS was with the WHO, NCEP and IDF criteria. Variables recorded were: socio-demographic data, CVD risk factors including lipids, obesity, diabetes, blood pressure and smoking habit and a glucose tolerance test outcome. Of the 720 individuals selected (age 60.3 +/- 11.5 years), 431 were female, 352 hypertensive, 142 diabetic, 233 pre-diabetic, 285 obese, 209 dyslipemic and 106 smokers. CVD risk according to the Framingham and REGICOR calculation was 13.8 +/- 10% and 8.8 +/- 9.8%, respectively. Using the WHO, NCEP and IDF criteria, MS was diagnosed in 166, 210 and 252 subjects, respectively and the relative risk of CVD complications in MS subjects was 2.56. Logistic regression analysis indicated that the MS components (WHO set), the MS components (IDF set) and the female gender had an increased odds ratio for CVD of 3.48 (95CI%: 2.26-5.37), 2.28 (95%CI: 1.84-4.90) and 2.26 (95%CI: 1.48-3.47), respectively. We conclude that MS and concomitant CVD risk is high in ostensibly normal population attending primary care clinics, and this would necessarily impinge on resource allocation in primary care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2008 |
|---|---|
| Erschienen: |
2008 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
BMC public health - 8(2008) vom: 22. Juli, Seite 251 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cabré, Joan-Josep [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
97C5T2UQ7J |
|---|
| Anmerkungen: |
Date Completed 08.09.2008 Date Revised 20.10.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/1471-2458-8-251 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM181094681 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM181094681 | ||
| 003 | DE-627 | ||
| 005 | 20231223160631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2008 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2458-8-251 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0604.xml |
| 035 | |a (DE-627)NLM181094681 | ||
| 035 | |a (NLM)18647383 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cabré, Joan-Josep |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Metabolic syndrome as a cardiovascular disease risk factor |b patients evaluated in primary care |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2008 | ||
| 500 | |a Date Revised 20.10.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a To estimate the prevalence of metabolic syndrome (MS) in a population receiving attention in primary care centers (PCC) we selected a random cohort of ostensibly normal subjects from the registers of 5 basic-health area (BHA) PCC. Diagnosis of MS was with the WHO, NCEP and IDF criteria. Variables recorded were: socio-demographic data, CVD risk factors including lipids, obesity, diabetes, blood pressure and smoking habit and a glucose tolerance test outcome. Of the 720 individuals selected (age 60.3 +/- 11.5 years), 431 were female, 352 hypertensive, 142 diabetic, 233 pre-diabetic, 285 obese, 209 dyslipemic and 106 smokers. CVD risk according to the Framingham and REGICOR calculation was 13.8 +/- 10% and 8.8 +/- 9.8%, respectively. Using the WHO, NCEP and IDF criteria, MS was diagnosed in 166, 210 and 252 subjects, respectively and the relative risk of CVD complications in MS subjects was 2.56. Logistic regression analysis indicated that the MS components (WHO set), the MS components (IDF set) and the female gender had an increased odds ratio for CVD of 3.48 (95CI%: 2.26-5.37), 2.28 (95%CI: 1.84-4.90) and 2.26 (95%CI: 1.48-3.47), respectively. We conclude that MS and concomitant CVD risk is high in ostensibly normal population attending primary care clinics, and this would necessarily impinge on resource allocation in primary care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Triglycerides |2 NLM | |
| 650 | 7 | |a Cholesterol |2 NLM | |
| 650 | 7 | |a 97C5T2UQ7J |2 NLM | |
| 700 | 1 | |a Martín, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Bernardo |e verfasserin |4 aut | |
| 700 | 1 | |a Piñol, Josep L |e verfasserin |4 aut | |
| 700 | 1 | |a Llor, Josep L |e verfasserin |4 aut | |
| 700 | 1 | |a Ortega, Yolanda |e verfasserin |4 aut | |
| 700 | 1 | |a Basora, Josep |e verfasserin |4 aut | |
| 700 | 1 | |a Baldrich, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Solà, Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Daniel, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández, Josep Ma |e verfasserin |4 aut | |
| 700 | 1 | |a Saumell, Judit |e verfasserin |4 aut | |
| 700 | 1 | |a Bladé, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Sagarra, Ramon |e verfasserin |4 aut | |
| 700 | 1 | |a Basora, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Montañés, Dolors |e verfasserin |4 aut | |
| 700 | 1 | |a Frigola, Joan L |e verfasserin |4 aut | |
| 700 | 1 | |a Donado-Mazarrón, Angel |e verfasserin |4 aut | |
| 700 | 1 | |a García-Vidal, Maria Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez-Oro, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a de Magriñà, Josep M |e verfasserin |4 aut | |
| 700 | 1 | |a Urbaneja, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Barrio, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Vizcaíno, Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Sabaté, Josep M |e verfasserin |4 aut | |
| 700 | 1 | |a Pascual, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Revuelta, Vanesa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC public health |d 2001 |g 8(2008) vom: 22. Juli, Seite 251 |w (DE-627)NLM111200962 |x 1471-2458 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2008 |g day:22 |g month:07 |g pages:251 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/1471-2458-8-251 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2008 |b 22 |c 07 |h 251 | ||